Hot Mandates: Venture Arm of Foundation

12 Apr

The fund not-for-profit subsidiary of the parent foundation. Launched in 2018 as the venture arm of the foundation and with $72 million under management, the fund focuses on making mission-related investments in companies with projects nearing clinical testing. The fund is geographically agnostic, and has an initial investment allocation range typically between $2M and $5M.

The fund was created to help accelerate life-changing outcomes for people with retinal degenerations through direct mission related investments in therapeutic companies. The mission of the parent foundation is to rapidly drive the research that will lead to preventions, treatments and cures for retinal degenerative diseases – including retinitis pigmentosa, age-related macular degeneration, Usher syndrome and the entire spectrum of retinal degenerative diseases.

The fund thesis is generally focused on therapeutic companies that range from nearing a pre-IND to clinically staged programs focused on inherited retinal disease (IRD) conditions and dry AMD. The fund is unique in that it can leverage the full weight of the parent foundation’s knowledge and resources including: natural history studies, world-class scientific advisory board and clinical consortium. As a result, the fund leverages both internal resources, and investment capital to attract additional investors and is open to using financial instruments including convertible notes, equity, fixed multiple return on investments, and/or royalties, with a preference for ground floor equity investments.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: